GSK PLC GSK StarRatingValueLabel_4Damien Conover, CFA - Sector Director - Morningstar Inc.

Period
Show Report Dates
View
GBP AmountCommon size as percentageCommon size as fraction
Rounding
ThousandBillion
Income Statement
20232022202120202019
Fiscal Year Ends31/12/202331/12/202231/12/202131/12/202031/12/2019
more...
Turnover30,328.0029,324.0024,696.0024,354.0033,754.00
EBITDA9,083.008,601.006,485.008,067.009,434.00
EBIT6,789.006,454.004,363.006,017.007,100.00
Operating Profit7,345.006,729.004,878.004,578.006,292.00
Pre-tax Profit6,064.005,628.003,599.005,170.006,221.00
Profit After Tax5,308.004,921.003,516.005,103.005,268.00
Profit For Financial Year4,928.0014,956.004,385.005,749.004,645.00
Retained Profit2,681.0011,489.00386.001,772.004,645.00
Normalized EPS p131.42115.0495.2386.34101.21
Balance Sheet
more...
Total Assets59,005.0060,146.0079,103.0080,431.0079,692.00
Total Liabilities46,210.0050,050.0057,761.0059,623.0061,335.00
Total Equity12,795.0010,096.0021,342.0020,808.0018,357.00
Cash Flow
more...
Cash Flow Per Share164.63181.27196.25209.45199.86
CAPEX PS-57.02-55.29-65.50-48.26-53.90
Dividends
more...
DPS p55.7576.25100.00100.00100.00
DPS Growth %-0.27-0.240.000.000.00
Dividend Yield (%) %3.47----

GBP in Millions except per share data.

Damien Conover, CFA - Sector Director - Morningstar Inc.
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures